ABT-288

ABT-288 · AbbVie

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABT-288, covering 2017-11-21 to 2018-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease [Phase 2]